Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- EUZ.F
- Price
- 58.00
- Stock movement up
- +0.50 (0.87%)
- Company name
- Eckert & Ziegler Strahlen- und Medizintechnik AG
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Markkapitalisasie
- 1.21B
- Ondernemingswaarde
- 1.36B
- Prys/Verkope
- 4.42
- Prys/Boek
- 4.85
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- 36.18
- Volgende P/E
- 32.77
- PEG
- -
- EPS groei
- 9.65%
- 1 jaar opbrengs
- 39.62%
- 3 jaar opbrengs
- -1.37%
- 5 jaar opbrengs
- 15.35%
- 10 jaar opbrengs
- 27.19%
Laaste opgedateer: 2025-03-05
DIVIDENDE
EUZ.F betaal nie dividende nie of geen data is ontvang nie
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | 36.18 |
| Prys tot OCF | 26.24 |
| Prys tot FCF | 53.41 |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | 4.42 |
| Prys tot Boekwaarde | 4.85 |
| EV tot verkope | 4.96 |
FINANSIËLE
Per aandeel
Loading...
Per aandeel gegewens
| Huidige aandeeltelling | 20.85M |
| EPS (TTM) | 1.60 |
| FCF per aandeel (TTM) | 1.09 |
Inkomstestaat
Loading...
Inkomstestaat gegewens
| Inkomste (TTM) | 273.50M |
| Bruto wins (TTM) | 131.98M |
| Bedryfsinkomste (TTM) | 57.30M |
| Netto inkomste (TTM) | 33.42M |
| EPS (TTM) | 1.60 |
| EPS (1j vorentoe) | 1.77 |
Marges
Loading...
Marges gegewens
| Bruto marge (TTM) | 48.26% |
| Bedryfsmarge (TTM) | 20.95% |
| Winsgrens (TTM) | 12.22% |
Balansstaat
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
| Kontant | 76.63M |
| Netto debiteure | 51.15M |
| Totale bedryfsbates | 265.91M |
| Klandisiewaarde | 37.43M |
| Ontasbare bates | 15.92M |
| Eiendom, aanleg en toerusting | 117.60M |
| Totale bates | 471.94M |
| Rekeninge betaalbaar | 5.34M |
| Kort/huidige langtermynskuld | 0.00 |
| Totale bedryfslaste | 91.47M |
| Totale laste | 222.88M |
| Aandeelhouersbelang | 249.06M |
| Netto tasbare bates | 0.00 |
Kontantvloei
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
| Bedryfskontantvloei (TTM) | 46.08M |
| Kapitale uitgawes (TTM) | 25.28M |
| Vrye kontantvloei (TTM) | 22.64M |
| Dividende betaal (TTM) | 0.00 |
Finansiële opbrengste
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
| Opbrengs op ekwiteit | 13.42% |
| Opbrengs op bates | 7.08% |
| Opbrengs op belegde kapitaal | 12.55% |
| Kontant opbrengs op belegde kapitaal | 8.50% |
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 57.90 |
| Daaglikse hoog | 58.40 |
| Daaglikse laag | 57.90 |
| Daaglikse volume | 1K |
| Hoogtepunt van alle tye | 138.00 |
| 1j analiseraaming | 56.50 |
| Beta | 1.33 |
| EPS (TTM) | 1.60 |
| Dividend per aandeel | - |
| Ex-dividend datum | 27 Jun 2024 |
| Volgende verdienste datum | 20 Mar 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| EUZ.F | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -57.97% | -4.76% |
| Hoogste prysdaling | -97.99% | -56.47% |
| Datum van hoogste daling | 3 Jan 2003 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -72.17% | -11.08% |
| Gemiddelde tyd tot nuwe hoogtepunt | 64 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 4939 days | 1805 days |
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
1.21B
Markkapitalisasie kategorie
Small-cap
Beskrywing
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Werknemers
1085
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
Germany
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
Key Insights Significant control over Eckert & Ziegler by individual investors implies that the general public has more...
18 Februarie 2025
In recent weeks, global markets have experienced significant volatility, with U.S. stocks facing pressure from AI competition fears and mixed corporate earnings results. While large-cap indices like t...
4 Februarie 2025
While Eckert & Ziegler SE ( ETR:EUZ ) might not have the largest market cap around , it received a lot of attention...
23 Januarie 2025
As the global markets navigate mixed performances and economic indicators signal caution, small-cap stocks continue to attract attention with their potential for growth amidst broader market fluctuati...
6 Januarie 2025
Most readers would already know that Eckert & Ziegler's (ETR:EUZ) stock increased by 5.3% over the past three months...
3 Januarie 2025
As global markets navigate the uncertainties surrounding the incoming Trump administration's policies, key indices like the S&P 600 for small-cap stocks have experienced notable fluctuations. Amid the...
22 November 2024
Amidst a backdrop of interest rate cuts by the European Central Bank and a modest rise in Germany's DAX index, investors are increasingly looking toward small-cap stocks as potential opportunities for...
21 Oktober 2024
As the German economy faces a forecasted contraction for the second consecutive year, attention turns to the potential opportunities within its stock market, particularly among small-cap companies tha...
18 Oktober 2024
As the German economy faces a challenging year with forecasts indicating a contraction and factory orders experiencing significant declines, investors are increasingly looking towards small-cap stocks...
15 Oktober 2024
As Germany's DAX index surged 4.03% recently, buoyed by hopes for interest rate cuts and China's stimulus measures, the broader European market sentiment appears cautiously optimistic despite signs of...
3 Oktober 2024
Volgende bladsy